Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden
· Delayed Price · Currency is SEK 3.160
-0.055 (-1.71%)
Apr 29, 2026, 5:24 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 156.04 million as of April 29, 2026. Its market cap has increased by 7.17% in one year.
Market Cap
156.04M
Enterprise Value
138.18M
Revenue
10.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.16
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 156.04M, an increase of 27.23%. That is a compound annual growth rate of 5.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 156.04M | -38.41% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AlzeCure Pharma AB | 160.88M |
| Alligator Bioscience AB | 151.06M |
| Diamyd Medical AB | 165.83M |
| Active Biotech AB | 175.03M |
| NextCell Pharma AB | 130.33M |
| Xbrane Biopharma AB | 196.16M |
| IRLAB Therapeutics AB | 122.99M |
| Initiator Pharma | 214.26M |